AKT1 and cancer: Although gain-of-function mutations in Rac and a constitutively active splice variant (Rac 1b) have been found in a number of cancer types [4–7], hyperactivation of Rac is for the most part associated with aberrant overexpression or hyperactivation of Rac-GEFs [8–11].